연구성과로 돌아가기

2023 연구자 정보 (51 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Seo, H.
(Seo, H)
Kyungpook Natl Univ, Chilgok Hosp, Dept Internal Med, Daegu, South Korea
Seoul Natl Univ, Dept Phys & Astron, Seoul 08826, South Korea


[JCR상위 1.5] Comparison of etoposide/cisplatin and irinotecan/cisplatin for extensive-stage small cell lung cancer in Koreans: A real-world retrospective observational study
[JCR상위 74.3] In situ measurement of relative attenuation length of gadolinium-loaded liquid scintillator using source data at RENO experiment
SCIE 1.5 ONCOLOGY;RESPIRATORY SYSTEM
INSTRUMENTS & INSTRUMENTATION
hyunsookim@sejong.ac.kr;
Seok, Jin Myoung
(Seok, JM)
Soonchunhyang Univ, Coll Med, Dept Neurol, Cheonan Hosp, Cheonan, South Korea
Soonchunhyang Univ, Cheonan Hosp, Coll Med, Dept Neurol, Cheonan, South Korea


[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
SCIE 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES
bjkim@skku.edu;sueh916@gmail.com;
Shin, Ha Young
(Shin, H)
Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea
Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea

0000-0002-4408-8265
Shin, Ha Young
[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
SCIE 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES
bjkim@skku.edu;sueh916@gmail.com;
Shin, Kyong Jin
(Shin, KJ)
Inje Univ, Haeundae Paik Hosp, Dept Neurol, Pusan, South Korea
Inje Univ, Haeundae Paik Hosp, Dept Neurol, Busan, South Korea
Inje Univ, Haeundae Paik Hosp, Dept Neurol, Coll Med, Busan, South Korea


[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis
SCIE 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES
CLINICAL NEUROLOGY
bjkim@skku.edu;sueh916@gmail.com;
paddy.waters@ndcn.ox.ac.uk;nrhong@gmail.com;
Shin, Y. K.
(Shin, YK)
Seoul Natl Univ, Seoul, South Korea

[JCR상위 1.5] EGFR Exon 20 Insertion Mutations in NSCLC: The Need for Accurate Naming Conventions and Implications for Personalized Therapy SCIE 1.5 ONCOLOGY;RESPIRATORY SYSTEM
Sinha, Ranjeet
(Sinha, R)
Aptose Biosci, San Diego, CA USA AAY-1094-2021
Kumar Sinha, Ranjeet

[JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) SCIE 1.5 HEMATOLOGY
Song, Ga-Young
(Song, GY)
Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea
Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, South Korea
Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Hwasun, Jeollanamdo, South Korea
Chonnam Natl Univ, Med Sch, Hwasun, Jeollanamdo, South Korea
Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Sch Med, Hwasun, Jeonranamdo, South Korea


[JCR상위 1.5] Multicenter, Prospective Study to Investigate the Efficacy and Safety of IntravenousImmunoglobulin Therapy in Elderly Patients with Diffuse Large B Cell Lymphoma Treated with R-Mini-CHOP
[JCR상위 17.7] ADVERSE PROGNOSIS OF LOW AR FLT3-ITD IN AML AND CLINICAL BENEFIT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN AML PATIENTS WITH LOW AR FLT3-ITD AND NPM1
[JCR상위 28.4] Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia
[JCR상위 33.1] Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)
[JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation
SCIE 1.5 HEMATOLOGY
HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION
ONCOLOGY
HEMATOLOGY;ONCOLOGY
f0115@jnu.ac.kr;
shglory@hanmail.net;HEMAKIM@yuhs.ac;
sksohn@knu.ac.kr;
Song, Ik Chan
(Song, IC)
Chungnam Natl Univ, Coll Med, Dept Internal Med, Daejeon, South Korea

[JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia SCIE 1.5 HEMATOLOGY
Song, J. -Y.
(Song, JY)
Samsung Med Ctr, Seoul, South Korea

[JCR상위 1.5] EGFR Exon 20 Insertion Mutations in NSCLC: The Need for Accurate Naming Conventions and Implications for Personalized Therapy SCIE 1.5 ONCOLOGY;RESPIRATORY SYSTEM
Song, S. Y.
(Song, SY)
Univ Ulsan, Coll Med, Asan Med Cenc, Seoul, South Korea

[JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy SCIE 1.5 ONCOLOGY;RESPIRATORY SYSTEM
Song, Si Yeol
(Song, SY)
Univ Ulsan, Asan Med Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea

[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR SCIE 1.5 ONCOLOGY;RESPIRATORY SYSTEM droij@jnu.ac.kr;
Sung, Jung-Joon
(Sung, JJ)
Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea
Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea
Seoul Natl Univ Hosp, Biomed Res Inst, Dept Neurol, Seoul, South Korea
Seoul Natl Univ, Med Res Council, Neurosci Res Inst, Dept Neurol,Coll Med, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea


[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
[JCR상위 13.4] Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis
SCIE 1.5 CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY
CLINICAL NEUROLOGY;NEUROSCIENCES
CLINICAL NEUROLOGY
bjkim@skku.edu;sueh916@gmail.com;
paddy.waters@ndcn.ox.ac.uk;nrhong@gmail.com;
Sung, M.
(Sung, M)
Sungkyunkwan Univ, Seoul, South Korea

[JCR상위 1.5] EGFR Exon 20 Insertion Mutations in NSCLC: The Need for Accurate Naming Conventions and Implications for Personalized Therapy SCIE 1.5 ONCOLOGY;RESPIRATORY SYSTEM
Uhm, Hyun-Seok
(Uhm, HS)
Natl Canc Ctr, Goyang, South Korea

[JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) SCIE 1.5 HEMATOLOGY
Uhm, Jieun
(Uhm, J)
Hanyang Univ, Coll Med, Seoul, South Korea KQU-5990-2024
Uhm, Jieun

[JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) SCIE 1.5 HEMATOLOGY
페이지 이동: